Endourology

The efficacy and safety of string stents after retrograde intrarenal surgery for urolithiasis: a systematic review and meta-analysis.

Ureteral stent insertion is frequently chosen after upper tract endourological procedures. The use of stents carrying a suture string is sometimes used to facilitate the extraction of the stent. In this systematic review and meta-analysis we aimed to provide stronger evidence for the efficacy of string stents, by comparing them to non-string stents, in matters of patients' Quality of Life (QoL), stent-related symptoms (SRS) and complications.

Single Session Endoscopic Removal of Bilateral Ureteric Stents Retained for Three Decades: A Case Report.

Forgotten ureteric stents are a devastating complication, which may require a multistage approach necessitating repeated surgeries and may even require removal of the entire renal unit. We report a 59-year-old woman with heavily encrusted bilateral ureteric stents forgotten for 32 years.

Level of knowledge on radiation exposure and compliance to wearing protective equipment: where do endourologists stand? An ESUT/EULIS survey.

Fluoroscopy is valuable in modern endourology. We present the results of a survey where compliance to radiation safety measures was tested according to surgical exposure, and level of understanding of the radiation rules and risks associated with it.

Trends in the Usage of Contrast Allergy Prophylaxis for Endourologic Procedures.

To characterize current practice patterns of urologists in the management of intravenous (IV) contrast allergy in the setting of endourologic procedures.

A survey was administered to all members of the Endourological Society to assess management of IV contrast allergy prior to ureteroscopy (URS) and percutaneous nephrolithotomy (PCNL).

Will stone density stop being a key factor in endourology? The impact of stone density on laser time using Lumenis laser p120w and standard 20w laser - a comparative study.

Introduction Ureteroscopy is the gold standard for most urinary tract calculi. Our institute recently incorporated a powerful 120w holmium laser machine integrating innovative technology (Lumenis® MOSES PulseTM120H Holmium:YAG laser, Lumenis Ltd.

Initial Experience with da Vinci Single-port Robot-assisted Radical Prostatectomies.

Single-port robotic surgery is being adopted for various surgical procedures. There have been interest in and clinical use of single-port robot-assisted radical prostatectomy (spRARP), but little reported data on feasibility and early outcomes.

Engineering & Urology Society - 34th Annual Meeting "Found in Translation"

Engineering and Society.jpg

The Engineering and Urology Society holds its 34th Annual Meeting: “Found in Translation”, on Sunday, May 5th in Chicago. The mission of the Engineering and Urology Society, a subsection of the Endourological Society, is to promote the development and application of new technology in urology through facilitating collaboration between engineers, physicists, and urologists.

Jaime Landman, M.D. and Zhamshid Okhunov, M.D. (meeting co-chairs) from the University of California, Irvine have organized a unique opportunity to better understand advanced contemporary urologic technologies and the process of successful technology development as presented by world class urologist and biotechnology industry leaders. Lectures on the thulium fiber laser, MRI fusion imaging, aquablation, applications of novel simulation technologies and role of artificial intelligence and machine learning in Urology will be presented. Expert lectures will be delivered on next generation approaches for urologic tissue repair and regeneration in lower urinary tract disease. Two keynote lectures will be presented: Dr. Ralph Clayman will review the role of immersive virtual reality as a disruptive technology in management of stones, renal masses and transplant surgery, and Dr. Peter Chang, co-director of the UCI Center for AI and Machine Learning, will review the role of AI and machine learning in urology today and in the future. Finally, for the first time in the history of the meeting, a CEO Roundtable, including 5 globally prominent CEO/Chair leaders (Dr. Arie Belldegrun, Dr. Ralph Clayman, Dr. Fred Moll, Mr. Abel Ang and Mr. Kurt Azabarzin) who have each had a major role in transforming urology via translational engineering, will share their experiences overcoming challenges in translation and delivering products from bench to bedside.

Two poster sessions in the afternoon provide researchers with the opportunity to present their work and update the attendees on the progress on the field and the latest innovations. The review of the abstracts for the poster sessions was performed online by a group of 47 reviewers from around the world. Each paper received between 11 and 13 reviews. We would like to thank the reviewers, listed at the end of this program book, for their essential contribution to the quality of the meeting and their constructive comments that they made for the research.

Based on the review scores, the Society presents the Best Paper Awards to “Intraoperative Guidance for Robotic Partial Nephrectomy using Surface-Based Registration: Initial Model Assessment” from the Department of Mechanical Engineering and Department of Urologic Surgery at Vanderbilt University, Nashville, TN and “Improving Prostate Cancer Margins Prediction with Machine Learning” from Avenda Health, Inc, Santa Monica, CA and David Geffen School of Medicine, UCLA, Los Angeles, CA. This is listed at the end of this program book, together with the Top 10 abstracts, and Best Reviewer Awards. The authors of all awarded abstracts are invited to submit full length articles to the Journal of Endourology on the respective topics. We gratefully thank all reviewers for their hard work, objective scoring, and contribution to the success of the meeting.

We welcome all urologists, engineers, and scientists to join us for this unique cross-disciplinary experience. As always, we thank Dr. George Nagamatsu the founder and first president of the society, and Dr. Jack Vitenson the first Society Treasurer for setting up the foundations based upon which we meet.


Program: Engineering and Urology Society - 34th Annual Meeting: “Found in Translation” 
Sunday, May 5th in Chicago, IL 
A complete version of this program including the abstracts presented.

7:00am                          Registration
7:50am – 8:00am Welcome
   
Jaime Landman, MD
Professor of Urology and Radiology, Chairman, Department of Urology, University of California Irvine
Zhamshid Okhunov, MD
Endourology Fellow, Department of Urology, University of California Irvine
 


8:00am –9:30am


The Disruptors and Translational Success


8:00 – 8:15    
Gregory Altshuler, PhD; President, IPG Medical Corporation             

Lasers in Urology: The Role of Thulium Fiber Lasers


8:15 – 8:30       
Peter Pinto, MD; Professor of Urology, National Cancer Institute  

MRI Fusion Imaging: Past, Present and Future


8:30 – 8:45      
Nikolai Aljuri, President and CEO, PROCEPT Biorobotics        

Aquablation: A Transformative Ablation


8:45 – 9:00     
Mihir Desai, MD 
Professor of Urology, Department of Urology, University of Southern California, Keck School of Medicine           

State of the Art Robotics


9:00 – 9:15      
Robert Sweet, MD 
Professor of Urology, University of Washington, Seattle          

Simulation in Urology: Where We Are And Where Are We Going


9:15 – 9:30 
Ralph Clayman, MD 
Professor of Urology, Dean Emeritus, Department of Urology, University of California, Irvine             

iVR: A Disruptive Technology

9:30am –10:00am     


Artificial Intelligence and Machine Learning


9:30 – 10:00         
Peter Chang, MD 
Director, Center of Artificial Intelligence in Diagnostic Medicine, University of California, Irvine


Artificial Intelligence & Machine Learning in Urology: Present and Future


10:00am – 10:30am   
Next Generation Approaches for Urologic Tissue Repair and Regeneration


10:00 – 10:15

Joshua Mauney, MD
Assistant Professor of Surgery, Department of Urology, Harvard Medical School

Surgical and Pharmacological Breakthroughs in the Management
Of Obstructive Bladder Disease


10:15 – 10:30

Trinity Bivalacqua, MD
Professor, Director of Urologic Oncology, James Buchanan Brady Urologic Institute, Johns Hopkins University

Surgical and Biomaterial Advances for Regeneration of the Lower, Urinary Tract


10:40am – 12:00pm   


CEO/Chair Roundtable: The Real Transformers Overcoming Challenges in Translation
1. Kurt Azabarzin, Vice President of R&D, CONMED Corporation  
2. Abel Ang, Chief Executive Officer, Dornier MedTech  
3. Fred Moll, Chairman and Chief Executive Officer, Auris Health, Inc.  
4. Ralph Clayman, MD; Professor of Urology, Dean Emeritus, Department of Urology, University of California, Irvine
5. Arie Belldegrun, MD; Professor of Urology, University of California, Los Angeles, Chairman, UroGen Pharma, Inc.
6. Questions and answers with the CEO/Chairs  


Meet the Real Transformers
Belldegrum_V02.jpg

AbelAng.jpg

Kurt Azarbarzin.jpg

Nikolai Aljuri.jpg
Frederic H. Moll.jpg
Coming Soon: Engineering & Urology Society at the AUA - What to Expect with Jaime Landman

Probe-Based Confocal Laser Endomicroscopy During Transurethral Resection of Bladder Tumors Improves the Diagnostic Accuracy and Therapeutic Efficacy.

This study was designed to assess the diagnostic accuracy and therapeutic efficacy of probe-based confocal laser endomicroscopy (pCLE), which provides real-time, in vivo histological information during transurethral resection of bladder tumors.

Evaluation of a new slim radial echoendoscope: A better option for an aging population.

The radial echoendoscope is still widely used for the investigation of abnormalities in the gastrointestinal wall and for stone detection in the extrahepatic biliary tree. Due to aging patient population, EUS is frequently performed in fragile and elderly individuals.

The Clinical Application of New Generation Super-Mini Percutaneous Nephrolithotomy in the Treatment of ≥20 mm Renal Stones.

To evaluate the safety and efficacy of new generation super-mini percutaneous nephrolithotomy (New-SMP) in the treatment of ≥20 mm renal stones.

We retrospectively analyzed the New-SMP procedures (14F) performed in the cases with ≥20 mm renal stones between April 1, 2016 and July 1, 2018.